Interview: natural toxin just the tonic for CK Life Sciences
This article was originally published in Scrip
Gourmets in Japan may be more accustomed to eating at least the safer parts of it, but the humble puffer fish has also given CK Life Sciences (CKLS) the potent neurotoxin upon which its lead drug development project is based.
You may also be interested in...
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.
Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform for Otezla growth.